A detailed history of Barclays PLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Barclays PLC holds 662,293 shares of BDX stock, worth $150 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
662,293
Previous 662,293 -0.0%
Holding current value
$150 Million
Previous $160 Million -0.0%
% of portfolio
0.04%
Previous 0.04%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$221.47 - $242.41 $10.5 Million - $11.5 Million
-47,499 Reduced 6.69%
662,293 $160 Million
Q2 2024

Aug 14, 2024

BUY
$225.07 - $246.17 $19 Million - $20.8 Million
84,438 Added 13.5%
709,792 $166 Million
Q1 2024

May 15, 2024

BUY
$233.45 - $247.73 $14.9 Million - $15.8 Million
63,957 Added 11.39%
625,354 $155 Million
Q4 2023

Feb 15, 2024

SELL
$232.24 - $267.23 $4.66 Million - $5.37 Million
-20,086 Reduced 3.45%
561,397 $137 Million
Q3 2023

Nov 07, 2023

BUY
$254.9 - $283.59 $22.6 Million - $25.1 Million
88,539 Added 17.96%
581,483 $150 Million
Q2 2023

Aug 03, 2023

BUY
$238.39 - $265.32 $73.8 Million - $82.1 Million
309,446 Added 168.64%
492,944 $130 Million
Q1 2023

May 04, 2023

SELL
$229.71 - $259.35 $93.3 Million - $105 Million
-406,014 Reduced 68.87%
183,498 $45.4 Million
Q4 2022

Feb 13, 2023

BUY
$218.29 - $256.91 $56.6 Million - $66.6 Million
259,142 Added 78.44%
589,512 $150 Million
Q3 2022

Nov 03, 2022

BUY
$51.03 - $264.23 $6.29 Million - $32.6 Million
123,356 Added 59.59%
330,370 $73.6 Million
Q2 2022

Aug 12, 2022

SELL
$234.74 - $275.42 $38.2 Million - $44.8 Million
-162,734 Reduced 44.01%
207,014 $51 Million
Q1 2022

May 16, 2022

SELL
$243.64 - $270.48 $24.5 Million - $27.2 Million
-100,603 Reduced 21.39%
369,748 $98.4 Million
Q4 2021

Feb 14, 2022

BUY
$230.08 - $250.94 $2.93 Million - $3.19 Million
12,726 Added 2.78%
470,351 $118 Million
Q3 2021

Nov 09, 2021

BUY
$232.72 - $256.47 $18 Million - $19.8 Million
77,389 Added 20.35%
457,625 $112 Million
Q2 2021

Aug 13, 2021

SELL
$232.65 - $254.58 $7.72 Million - $8.45 Million
-33,192 Reduced 8.03%
380,236 $92.5 Million
Q1 2021

May 13, 2021

BUY
$232.09 - $256.88 $19.3 Million - $21.3 Million
82,962 Added 25.1%
413,428 $101 Million
Q4 2020

Feb 11, 2021

SELL
$221.92 - $245.94 $104 Million - $116 Million
-470,214 Reduced 58.73%
330,466 $82.7 Million
Q3 2020

Nov 12, 2020

BUY
$215.77 - $276.76 $133 Million - $170 Million
614,718 Added 330.56%
800,680 $186 Million
Q2 2020

Aug 12, 2020

SELL
$219.9 - $263.41 $2.24 Million - $2.68 Million
-10,177 Reduced 5.19%
185,962 $44.5 Million
Q1 2020

May 13, 2020

SELL
$195.69 - $279.01 $37.1 Million - $52.9 Million
-189,646 Reduced 49.16%
196,139 $45.1 Million
Q4 2019

Feb 10, 2020

SELL
$236.45 - $266.82 $38.5 Million - $43.4 Million
-162,672 Reduced 29.66%
385,785 $105 Million
Q3 2019

Nov 14, 2019

BUY
$230.58 - $256.08 $50 Million - $55.6 Million
217,001 Added 65.47%
548,457 $139 Million
Q2 2019

Aug 14, 2019

BUY
$217.4 - $246.08 $11.7 Million - $13.2 Million
53,791 Added 19.37%
331,456 $83.5 Million
Q1 2019

May 15, 2019

SELL
$206.05 - $248.17 $17 Million - $20.5 Million
-82,470 Reduced 22.9%
277,665 $69.3 Million
Q4 2018

Feb 14, 2019

SELL
$204.73 - $257.93 $935,206 - $1.18 Million
-4,568 Reduced 1.25%
360,135 $81.1 Million
Q3 2018

Nov 14, 2018

BUY
$233.07 - $256.0 $8.29 Million - $9.1 Million
35,561 Added 10.8%
364,703 $95.2 Million
Q2 2018

Aug 14, 2018

SELL
$208.1 - $233.85 $26.2 Million - $29.4 Million
-125,893 Reduced 27.67%
329,142 $78.8 Million
Q1 2018

May 15, 2018

BUY
$205.46 - $240.27 $29.8 Million - $34.8 Million
144,974 Added 46.76%
455,035 $98.6 Million
Q4 2017

Feb 14, 2018

BUY
$189.0 - $222.64 $22.7 Million - $26.7 Million
119,914 Added 63.06%
310,061 $66.4 Million
Q3 2017

Nov 14, 2017

BUY
$186.89 - $198.9 $35.5 Million - $37.8 Million
190,147
190,147 $37.3 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64.7B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.